| Summary: | John C Carlson,1 Monica Hajirawala,2 Nina Hein3 1Department of Pediatrics, Ochsner Health System, New Orleans, LA, USA; 2Department of Pediatric Allergy and Immunology, University of South Florida, St. Petersburg, FL, USA; 3Department of Allergy and Clinical Immunology, Tulane University, New Orleans, LA, USACorrespondence: John C Carlson, Department of Pediatrics, Ochsner Health System, 1315 Jefferson Hwy, New Orleans, LA, 20121, USA, Tel +1-504-842-3900, Fax +1-504-842-5848, Email john.carlson@ochsner.orgAbstract: While guidelines recommend testing and treatment for patients with venom-induced anaphylaxis to prevent morbidity and mortality, significant barriers prevent most patients from receiving the evaluation and treatments that they need. This review examines these barriers in the United States along with the facilitators that can be used to overcome them.Keywords: insect hypersensitivity, venom, anaphylaxis, immunotherapy, social determinants of health
|
|---|